🇺🇸 SECHaleon plcQwen · 实盘不做把握 0/10不做原因:不是事件
北京时间·🕒 发布 19:51:06·⟳ 抓取 19:51:30 +24s·⚡ 决策 09-01 19:52:20 +50s·56.0 天前
Haleon plc 例行月度投票权与股本披露（6-K），无任何新增实质信息
该 6-K 是 Haleon 按英国 FCA 规则每月例行发布的投票权与股本通知，仅报告截至月末的总股数和库存股数，不含任何业务、财务、战略或资本结构新信息，不构成可交易催化。
📄 原文Haleon plc↗ 原文
----- a6350s.htm ----- 6-K 1 a6350s.htm TOTAL VOTING RIGHTS AND CAPITAL a6350s UNITED STATES SECURITIES AND EXCHANGE CO…
不做 Haleon plc（HLN.US）
例行月度投票权与股本行政备案，无任何新增实质信息，不构成可交易催化
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Haleon plc 于 2026-09-01 向 SEC 提交 Form 6-K，内容为截至 2026年8月31日的总股本（8,808,341,409 股）和投票权数（8,796,548,784 股）的例行月度披露。这是英国上市公司按 FCA DTR 规则必须每月发布的行政性通知，用于持股披露门槛计算的分母更新。无新增业务、财务、并购或资本结构信息，不构成任何交易催化。
🔎 新鲜度:最早出现 2026-09-01 · 扩散 low · price-in 风险 low ↗
先例如何影响了这次决策
对本次决策的影响:无
方向:无需先例——例行行政备案无历史价格反应可参考
涨幅量级:不适用
形态:不适用
原文全文
展开原文 · 2,537 字
----- a6350s.htm -----
6-K
1
a6350s.htm
TOTAL VOTING RIGHTS AND CAPITAL
a6350s
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
Form
20-F
☒
Form
40-F
☐
EXHIBIT INDEX
Exhibit
Number
Description
99.1
01
September 2026 -
“Total Voting
Rights and Capital”
99.1
Haleon plc: Total Voting Rights and Capital
01 September 2026:
As
at 31 August 2026 the total number of shares issued by Haleon plc
("Haleon" or the "Company") is 8,808,341,409
ordinary
shares of £0.01 each, of which 11,792,625 are held as treasury
shares.
Therefore, the number of ordinary shares with voting rights is
8,796,548,784 and this figure should be used by shareholders (and
others with notification obligations) as the denominator for the
calculation by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency
Rules.
Notifiable interests in Haleon may be sent to:
company.secretary@haleon.com
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused
on better everyday health. Our people, our brands, our research,
our investment and our innovation are aimed at improving the
everyday health of consumers. Our product portfolio spans six major
categories - Oral Health, Vitamins, Minerals and Supplements (VMS),
Pain Relief, Respiratory Health, Digestive Health and Therapeutic
Skin Health and Other. Our superior brands - such
as
Advil
,
Centrum
,
Otrivin
,
Panadol
,
parodontax
,
Polident
,
Sensodyne
,
Theraflu
and
Voltaren
- are trusted by more than one billion
consumers and are recommended by health professionals around the
world.
For more information, please visit
www.haleon.com
.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
HALEON PLC
(Registrant)
Date:
September 01, 2026
By:
/s/
Amanda Mellor
Name:
Amanda
Mellor
Title:
Company
Secretary
6-K
1
a6350s.htm
TOTAL VOTING RIGHTS AND CAPITAL
a6350s
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
Form
20-F
☒
Form
40-F
☐
EXHIBIT INDEX
Exhibit
Number
Description
99.1
01
September 2026 -
“Total Voting
Rights and Capital”
99.1
Haleon plc: Total Voting Rights and Capital
01 September 2026:
As
at 31 August 2026 the total number of shares issued by Haleon plc
("Haleon" or the "Company") is 8,808,341,409
ordinary
shares of £0.01 each, of which 11,792,625 are held as treasury
shares.
Therefore, the number of ordinary shares with voting rights is
8,796,548,784 and this figure should be used by shareholders (and
others with notification obligations) as the denominator for the
calculation by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency
Rules.
Notifiable interests in Haleon may be sent to:
company.secretary@haleon.com
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused
on better everyday health. Our people, our brands, our research,
our investment and our innovation are aimed at improving the
everyday health of consumers. Our product portfolio spans six major
categories - Oral Health, Vitamins, Minerals and Supplements (VMS),
Pain Relief, Respiratory Health, Digestive Health and Therapeutic
Skin Health and Other. Our superior brands - such
as
Advil
,
Centrum
,
Otrivin
,
Panadol
,
parodontax
,
Polident
,
Sensodyne
,
Theraflu
and
Voltaren
- are trusted by more than one billion
consumers and are recommended by health professionals around the
world.
For more information, please visit
www.haleon.com
.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
HALEON PLC
(Registrant)
Date:
September 01, 2026
By:
/s/
Amanda Mellor
Name:
Amanda
Mellor
Title:
Company
Secretary
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。